On December 2, 2021, Beijing Investment Promotion Service Center successfully held the Online Promotion Conference of Medicine and Health Industry of the "Two Zones" in Beijing. Beijing Municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park, Beijing Municipal Health Commission, Beijing Municipal Bureau of Economy and Information Technology, and other units interpreted the relevant policies. Changping District and Daxing District promoted the business environment and industrial policies of key functional areas such as Life Science Park and Biomedical Base. 

The medicine and health industry leads the industrial development of the "two zones". The medicine and health industry is one of the "dual engines" driving Beijing's innovative development and is also the pillar of the economy in China (Beijing) Pilot Free Trade Zone. According to the data of the Beijing Municipal Science & Technology Commission and Administrative Commission of Zhongguancun Science Park, the scale of Beijing's medicine and health industry had reached RMB 220 billion against the trend under the influence of epidemic and bulk-buying by the end of 2020. A number of innovative drug companies with high growth vigor have emerged, such as BeiGene, Innocare, Jacobio, and Huahui Health, and potential innovative companies have been introduced, such as Brii Biosciences, United Imaging, and BioFront. Innovative achievements have been made with 7 innovative drugs approved for marketing in Beijing and 7 AI Class-III medical device products approved for marketing, all of which are in the leading position in China.

Policy dividends of the medicine and health industry have been released quickly. According to the Beijing Municipal Science & Technology Commission and Administrative Commission of Zhongguancun Science Park, the Beijing Municipal People's Government published the "Action Plan for Accelerating Collaborative Innovation in Medicine and Health (2021-2023)", intending to promote high-quality development of medicine and health industry in Beijing, and put forward 20 effective initiatives in 5 aspects. With three-year efforts, the industry revenue is expected to exceed RMB 300 billion by 2023. There will be no less than 3,000 mu of newly approved industrial land. Relying on national strategic science and technology strength and gathering global innovation resources, Beijing strives to achieve original breakthroughs in frontier fields such as life sciences and introduces multi-level innovation talents. Meanwhile, the number of innovative drugs and innovative medical devices submitted for listing will reach 90, newly listed enterprises will increase by 25, and 1-2 research hospitals of international first-class standards will be built.

Accelerate the construction of a medical-industrial integration innovation system with the construction of research wards guiding it. Beijing Municipal Health Commission introduced that Beijing will accelerate the construction of a medical-industrial integration innovation system. First, it will establish professional institutions to promote the development of science and technology of medicine and health. The newly established "Beijing Medicine and Health Science and Technology Promotion Center" will bridge the communication and service between the supply side and demand side of medical and health science and technology, which is also a concrete embodiment of the implementation of the action plan. Second, it will strengthen the medical-industrial integration, establish a solid cooperation mechanism between scientific research institutes and enterprises taking the mutual employment of the talents among hospitals, institutes, and enterprises as a focus, and jointly accelerate the development of the technology R&D of medicine and health products. Third, it will improve the level of digitalization and informationization of clinical research, and establish a big data platform for medical research and formulate local standards for clinical research data elements for specialized diseases. Fourth, it will make up for the shortage of research wards, strengthen the layout of specialties in traditional Chinese medicine and pediatrics, and build the second and third batches of research wards on merit.

Focus on high-end standards to promote the innovative development of Beijing's medicine and health industry. The Beijing Municipal Bureau of Economy and Information Technology interpreted the idea of focusing on high-end standards to promote the innovative development of Beijing's medicine and health industry. According to the Plan on the Construction of Beijing Science and Technology Innovation Center During the 14th Five-Year Plan Period, Beijing will make every effort to promote the construction of a high-precision economic structure and support the priority development of the "double engine" industries of new-generation information technology and medicine and health. In terms of medicine and health industry, Beijing will focus on three major directions: innovative drugs, new apparatus, and new health services, build up leading advantages in new vaccines, next-generation antibody drugs, cell-and gene-therapy, and domestic high-end medical equipment, and promote the parallel development of pharmaceutical manufacturing and health services.

A "one in the north and one in the south" development pattern of the medicine and health industry has been in place for coming "Life Valley" and the life health industry of Beijing Airport Economic Core Zone of Beijing Daxing International Airport. In the north, Changping District is strengthening the transformation services for cutting-edge innovation projects and the construction of specialized incubators; in the south, Daxing District is focusing on reinforcing the priority guarantee of industrial space, accelerating the construction of standard workshops, and proactively undertaking the implementation of scientific and technological innovation achievements in the north as well as achievements around the world.

The Administrative Committee of Zhongguancun Life Science Park introduced the construction progress of the Park. The "Life Valley" will focus on cutting-edge AI medicine, dominate the cutting-edge biotechnology, consolidate the innovative medical apparatus and precision medicine, accelerate the breakthrough of cutting-edge technology and the incubation of high-precision enterprises, and form an innovation highland of the medicine and health industry with more characteristics. As for development space, Zhongguancun Life Science Park will speed up the development and construction of the third phase of the Park to build a beautiful, inclusive, public, and vital district with scientific and technological innovation and accelerate the construction of innovation corridor of the "Life Valley". To support projects of the medicine and health industry to be implemented, make enterprises stronger and bigger, transform R&D innovation results and promote the development of professional third-party service platforms, Changping District also sets up a special fund for industrial development to grant rewards, subsidies, discount interests, equities, and other funds according to the actual situation.

Daxing District Investment Promotion Service Center promoted the business environment and industrial policies for Beijing Airport Economic Core Zone and Daxing Biological and Pharmaceutical Industrial Base. According to the foregoing Plan, Beijing Airport Economic Core Zone will underline the international life health industry, prioritize the development of biopharmaceuticals, stem cell technology, cell therapy, CRO, CDMO, high-end medical consumables and implantable apparatus, genetic detection and precision medicine, and transforming of integrated medical-industrial achievements, etc. For eligible enterprises or products, corresponding financial support and one-time incentives will be granted. As the largest biopharmaceuticals industry base in Beijing, Daxing Biological and Pharmaceutical Industrial Base boasts over 5,000 registered enterprises and 540 enterprises in operation, including 167 high-tech enterprises, 18 listed enterprises, and 66 industrial enterprises above designated size. A complete structure of industrial chain covering "drug research and development, clinical trials, administrative drug examination and approval, pilot production, manufacturing, drug circulation, and health services" has been formed and the advantages of the industrial chain are second to none in China.

It is known that the Online Promotion Conference of Medicine and Health Industry of the "Two Zones" in Beijing is one of the promotion events organized by the Beijing Investment Promotion Service Center. It aimed to further promote the policies and measures for the construction of the "Two Zones" in Beijing, release positive signals of open development to market entities, and stimulate investment promotion. Nearly 300 domestic and foreign enterprises, investment institutions, research and development institutions, and medical institutions in the medicine and health industry attended the event.